EVPL and cancer: The prognostic accuracy of p210 was evaluated in the Malmö Diet and Cancer Cohort (n = 5,393, with a follow-up of more than 15 years) and demonstrated that higher IgG titers against native p210 conferred protection against coronary events [adjusted hazard ratio (95% confidence interval), 0.73 (0.56–0.97); P = 0.029] (12).